Latest filing published 06 Apr 2015 for Karyopharm Therapeutics Inc., €136k.
Insider track record
No signal scores available.
Kenneth E. Weg: trading record in brief
This profile gathers the share dealings of Kenneth E. Weg across 3 companies, led by Aveo Pharmaceuticals, Inc., Karyopharm Therapeutics Inc. and Millennium Pharmaceuticals Inc. The record holds 7 filings, for trades running from 9 May 2008 to 2 April 2015.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 6 April 2015: a share grant of €136k, in Karyopharm Therapeutics Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kenneth E. Weg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$29.55Common StockSEC:0001209191-15-032717:0
- 4,541 shares@ US$2.56Common StockSEC:0001181431-13-037957:0
- 1,724 shares@ US$7.25Common StockSEC:0001181431-13-023329:0
- 41,492 sharesCommon StockSEC:0001181431-10-017230:0
- 200,000 sharesCommon StockSEC:0001181431-10-017230:1
- 230,769 sharesCommon StockSEC:0001181431-10-017230:2
- 10,000 shares@ US$25.00Common StockSEC:0001179110-08-009461:0
7 of 7 declarations
